The National Diabetes & Obesity Institute Launches Affiliation with Cleveland Clinic

The National Diabetes & Obesity Research Institute (NDORI) today in Mississippi announced an affiliation with the Cleveland Clinic Endocrinology & Metabolism Institute designed to enhance diabetes- and obesity-related research, discover better treatment protocols, and, ultimately, cultivate a healthier Mississippi and nation.

The affiliation combines the academic, clinical and research components of the Cleveland Clinic Endocrinology & Metabolism Institute with the newly formed diabetes and research institute. The Ohio-based Cleveland Clinic Endocrinology & Metabolism Institute is ranked No. 3 in the nation for diabetes care by U.S. News & World Report.

“I am delighted to announce this groundbreaking affiliation with the Cleveland Clinic Endocrinology & Metabolism Institute. Their extensive expertise in diabetes, obesity, and endocrinology research is an essential element in establishing NDORI as the preeminent diabetes and obesity research center in the United States,” says Phil Bryant, governor of the State of Mississippi. “Diabetes and prediabetes affects over one million people in the state of Mississippi, almost a third of our population, so there is no greater place to conduct this groundbreaking research.”

“The hope is that the National Diabetes & Obesity Research Institute will help find a cure and enhance healthcare, not only in Mississippi but across the United States,” says lieutenant governor Tate Reeves. “Improving the health and well-being of our citizens afflicted by diabetes also makes good fiscal policy for the state as healthcare programs are hit by related costs. With this new research, better protocols and treatments, we can reduce this number and improve our overall healthcare system.”

NDORI is the vision of Joseph C. Canizaro, real estate developer and philanthropist. Canizaro’s passion for diabetes research and drive to find a cure comes from his personal experience with type 2 diabetes.

NDORI will be part of a 150-acre learning medical city located in the Tradition community on the Mississippi Gulf Coast and will be modeled after successful research centers at the heart of communities that are anchored by healthcare and educational organizations.

NDORI will work closely with a core team of Cleveland Clinic Endocrinology & Metabolism Institute experts, led by Richard Shewbridge, MD, an endocrinologist and the executive medical director for this affiliation.

“Thanks to this affiliation, NDORI and the Cleveland Clinic Endocrinology & Metabolism Institute will join forces to advance diabetes research and fight diabetes,” said Dr. Shewbridge. “We will focus on four strategic areas: diabetes and obesity research, diabetes and obesity clinical care, patient and provider education, and an outcomes and research database.”

James Young, MD, a cardiologist and chairman of the Cleveland Clinic Endocrinology & Metabolism Institute said, “With this affiliation, NDORI and the Cleveland Clinic Endocrinology & Metabolism Institute will compare different approaches in various locations, including Mississippi, the Gulf Coast, and Ohio. This is an exciting opportunity to further our mission of finding better approaches to managing the scourge of diabetes and obesity in America.”

According to the Centers for Disease Control and Prevention (CDC), nearly 30 million Americans have diabetes – that’s about 1 out of every 11 people nationwide. The American Diabetes Association (ADA) estimates that 15.4 percent of the population in Mississippi has diabetes. And, about 13.5 percent of the population in Ohio has diabetes.

Once the affiliation with the Cleveland Clinic Endocrinology & Metabolism Institute is fully implemented, the patients of NDORI will enjoy greater access to best practices related to diabetes and obesity treatment. Leading Mississippi healthcare systems, such as Memorial Hospital and Coastal Family Health Centers,William Carey University’s nursing and medical related programs, as well as the Mississippi Gulf Coast Community College will have an opportunity to access NDORI’s resources via an affiliate program.

In the future, NDORI would like to expand its scope of work beyond the Mississippi Gulf Coast to the rest of the state and the nation, including rural areas where multiple underserved or uninsured individuals are affected by diabetes.

You may also like

  • Circulating microRNAs Likely as Effective as A1C for Predicting Type 2 Diabetes in Youth

    Measuring the circulating abundance of microRNAs is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Jeanie Tryggestad, MD, an associate professor of pediatrics…

  • Two Medication Classes Reduced Cardiovascular and Liver Events in People with Type 2 Diabetes

    GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data presented at ENDO 2024. Researchers reviewed Medicare data documented from 2013 to 2020 and a large U.S. health insurance database from 2013 to 2022. They performed…